Jazz Pharmaceuticals
JAZZ
JAZZ
570 hedge funds and large institutions have $12.3B invested in Jazz Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 226 increasing their positions, 163 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4.06% more ownership
Funds ownership: 101.57% → 105.63% (+4.1%)
1% less funds holding
Funds holding: 573 → 570 (-3)
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
Holders
570
Holding in Top 10
13
Calls
$59.1M
Puts
$47.6M
Top Buyers
| 1 | +$258M | |
| 2 | +$166M | |
| 3 | +$90.4M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$80.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$60.4M |
Top Sellers
| 1 | -$127M | |
| 2 | -$93.2M | |
| 3 | -$63.2M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$49.3M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$41.6M |
